Literature DB >> 23416322

Loss of cholinergic phenotype in septohippocampal projection neurons: relation to brain versus peripheral IL-2 deficiency.

Danielle M Meola1, Zhi Huang, Michael King, John M Petitto.   

Abstract

In the peripheral immune system, IL-2 is essential for immune homeostasis, normal T regulatory cell function, and self-tolerance. IL-2 knockout (IL-2KO) mice develop spontaneous autoimmunity characterized by increased T cell trafficking to multiple organs. The IL-2 gene is also expressed in the brain, and in vitro studies have shown that IL-2 is a potent modulator of acetylcholine release from septohippocampal neurons and exerts trophic effects on septal neurons in culture. We previously described the apparent loss of cholinergic cell bodies in the medial septum of IL-2KO mice. Here we investigated if loss of brain-derived IL-2, or autoimmunity stemming from loss of peripheral IL-2, is responsible for the alteration in choline acetyltransferase (ChAT) expression in the medial septum of IL-2KO mice. To accomplish this objective, we compared ChAT-positive neurons between wild-type (WT) mice, IL-2KO mice, and congenic mice with a double gene deletion for the IL-2 gene and the recombinase activating gene-2 (RAG-2) which are referred to as IL-2KO/RAG-2KO mice (congenic mice which lack mature T and B cells as well as peripheral and brain-derived IL-2). We found that the loss of ChAT staining did not coincide with an overall loss of cells in the medial septum, suggesting that loss of brain IL-2 results in a change in cholinergic phenotype unrelated to cell death. No differences were noted in the endogenous expression of cytokines and chemokines tested in the medial septum. Evaluation of BDNF and NGF levels between WT and IL-2KO mice in medial septal homogenates revealed that IL-2KO mice have markedly higher levels of NGF in the medial septum compared to WT mice. Our findings suggest that brain-derived IL-2 plays an essential role in the maintainance of septohippocampal projection neurons in vivo. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416322      PMCID: PMC3740576          DOI: 10.1016/j.neulet.2013.01.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

1.  Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices.

Authors:  D Seto; S Kar; R Quirion
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

Review 2.  IL-2, regulatory T cells, and tolerance.

Authors:  Brad H Nelson
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

3.  Prior facial motor neuron injury elicits endogenous T cell memory: relation to neuroregeneration.

Authors:  Grace K Ha; Zhi Huang; John M Petitto
Journal:  J Neuroimmunol       Date:  2007-01-17       Impact factor: 3.478

4.  Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout.

Authors:  Ray D Beck; Michael A King; Zhi Huang; John M Petitto
Journal:  Brain Res       Date:  2002-11-15       Impact factor: 3.252

5.  Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors.

Authors:  M Besser; R Wank
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

Review 6.  IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.

Authors:  Laurence A Turka; Patrick T Walsh
Journal:  Front Biosci       Date:  2008-01-01

7.  Role of the cholinergic system in the regulation of neurotrophin synthesis.

Authors:  J Yu; D P Pizzo; L A Hutton; J R Perez-Polo
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

8.  Immune responses in interleukin-2-deficient mice.

Authors:  T M Kündig; H Schorle; M F Bachmann; H Hengartner; R M Zinkernagel; I Horak
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

9.  Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

Authors:  U K Hanisch; D Seto; R Quirion
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

10.  BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype.

Authors:  Ignacio Lopez-Coviella; Tiffany J Mellott; Aletta C Schnitzler; Jan K Blusztajn
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

View more
  5 in total

1.  5. T cell immunity and neuroplasticity.

Authors:  Zhi Huang; Grace K Ha; John M Petitto
Journal:  Recent Res Dev Neurosci       Date:  2013

2.  Reversal of Neuronal Atrophy: Role of Cellular Immunity in Neuroplasticity and Aging.

Authors:  Zhi Huang; Grace Ha; John Petitto
Journal:  J Neurol Disord       Date:  2014-07

3.  Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.

Authors:  John M Petitto; Jesse D Cushman; Zhi Huang
Journal:  J Neurol Disord       Date:  2015

4.  Selective Neuronal and Brain Regional Expession of IL-2 in IL2P 8-GFP Transgenic Mice: Relation to Sensorimotor Gating.

Authors:  Danielle Meola; Zhi Huang; John M Petitto
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-10-28

5.  Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy?

Authors:  Hani Koh; Kyoujung Hwang; Hae-Young Lim; Yong-Joo Kim; Young-Ho Lee
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.